Organigram Holdings Acquires Motif Labs Ltd.
December 6, 2024
Organigram Holdings Inc. acquired 100% of Motif Labs Ltd. for $90 million upfront consideration (C$50M cash and C$40M in Organigram common shares) plus up to C$10M contingent share consideration. The acquisition gives Organigram #1 market share in the Canadian recreational cannabis market, adds Motif's extraction and high‑volume vape/IPR manufacturing capabilities and a Southwestern Ontario distribution hub, and is expected to deliver >C$10M of cost synergies over ~24 months.
- Buyers
- Organigram Holdings Inc.
- Targets
- Motif Labs Ltd.
- Sellers
- Motif Labs Ltd. shareholders
- Industry
- Consumer Products
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Organigram Holdings Inc. Acquires Laurentian Organic Inc.
December 21, 2021
Consumer Products
Organigram Holdings Inc. acquired all of the issued and outstanding shares of Laurentian Organic Inc. in a cash-and-share transaction with aggregate upfront consideration of CAD 36 million plus potential earnouts. The acquisition brings the Tremblant Cannabis and Laurentian craft brands into Organigram’s portfolio, strengthens its presence in Quebec, and expands its premium/hash product offering to accelerate revenue and EBITDA growth.
-
Organigram Acquires Collective Project Limited to Enter U.S. Hemp-Derived THC Beverage Market
April 1, 2025
Food & Beverage
Organigram Global Inc. acquired 100% of Collective Project Limited for approximately C$6.2 million upfront, with milestone and earnout payments linked to future beverage revenue that could bring total contingent consideration to C$24 million. The deal gives Organigram an immediate footprint in the U.S. hemp-derived THC beverage market and accelerates its entry into the cannabis beverage category in Canada by adding Collective Project’s ready-to-drink hemp/cannabis beverage portfolio and existing U.S. retail listings.
-
Organigram Invests Additional $2.5M in Hyasynth Biologicals
December 22, 2021
Biotechnology
Organigram Holdings Inc. has invested an additional $2.5 million in secured convertible debentures of Hyasynth Biologicals Inc., bringing its total investment to $10.0 million. The financing is intended to advance Hyasynth's production scalability, R&D into rare cannabinoids and commercial partnerships as the company scales fermentation-based cannabinoid manufacturing.
-
GrowerIQ Acquires Ample Organics from Akerna
January 15, 2024
Software
Toronto-based GrowerIQ has acquired fellow cannabis software provider Ample Organics from U.S.-based Akerna in an all-cash deal that closed in December; financial terms were not disclosed. The acquisition brings Ample's seven employees onto GrowerIQ's ~25-person team and combines two seed-to-sale ERP platforms to create what GrowerIQ calls the largest cannabis tech platform in Canada (and a stronger position in Europe).
-
Curaleaf Holdings Acquires Northern Green Canada
March 19, 2024
Pharmaceuticals
Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.
-
Symeres Acquires Organix Inc.
April 26, 2022
Biotechnology
Symeres, a European drug discovery CRO/CDMO backed by Keensight Capital, has acquired Organix Inc., a Woburn, Massachusetts-based organic chemistry services provider specializing in lipids. The deal gives Symeres a strategic US foothold and expands its capabilities into the fast-growing lipids market supporting mRNA therapeutics and vaccines; Organix generates over $10 million in revenue and has roughly 45 employees.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.